Current Guidelines For Prescribing Testosterone On The PBS Banner

Current Guidelines For Prescribing Testosterone On The PBS

Categories:

 Andrology-Australia_logo

The Pharmaceutical Benefits Advisory Committee announced new prescribing criteria for testosterone effective from the 1st of April 2015. The main changes that were made are as follows;

  • Newly identified androgen deficient men need to be referred to an endocrinologist, urologist, paediatrician or registered member of the Chapter of Sexual Health Medicine to obtain access to the PBS subsidised treatment.
  • Existing patients on PBS subsidised testosterone must be referred to an endocrinologist, urologist, paediatrician or registered member of the Chapter of Sexual Health Medicine for the continuation of subsidised treatment.
  • Blood testosterone qualifying levels has been lowered from 8nmol/L to 6nmol/L.

Andrology Australia in conjunction with the Endocrine Society have released an advisory note for prescribers on how to implement the new PBS changes for testosterone prescribing with specific emphasis on the fact that there is no ‘grandfather’ clause. This means that if a man previously had two serum testosterone levels below 8nmol/L but above 6 nmol/L they no longer qualify for PBS subsidised testosterone and require a review. The general practitioner can continue treatment using a private, non-PBS prescription if necessary. The full advisory note can be found at;

www.andrologyaustralia.org/wp-content/uploads/PBS-testosterone-implementation-2015.pdf

Latest News


In Australia, is Addyi (Flibanserin) available or what is available? In Australia, is Addyi (Flibanserin) available or what is available?

 Australia Leads the Way in Androgen Treatment for Women with HSDD While the US-approved drug flibanserin offers limited benefit for Hypoactive Sexual Desire Disorder (HSDD), it’s… Continue Reading →

How Satisfied are you with Your Sex Life? How Satisfied are you with Your Sex Life?

Let’s Talk About Sexual Satisfaction—It Matters More Than You Think Did you know that 4 in 10 women experience sexual concerns during mid-life? Yet many suffer… Continue Reading →

MHRA approves testosterone cream for UK postmenopausal women MHRA approves testosterone cream for UK postmenopausal women

  MHRA approves testosterone cream for UK postmenopausal women   12 August 2025 Perth, Australia and Guildford, England:   Lawley Pharmaceuticals and its commercial… Continue Reading →